Loading clinical trials...
Loading clinical trials...
A 2-Part Open-Label Study to Assess the Clinical Benefit and Long-Term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, or Psoriatic Arthritis
Conditions
Interventions
Etanercept
Locations
42
Australia
Pfizer Investigational Site
Westmead, Sydney, New South Wales, Australia
Pfizer Investigational Site
Parkville, Melbourne, Victoria, Australia
Pfizer Investigational Site
Ghent, Belgium, Belgium
Pfizer Investigational Site
Brussels, Belgium
Pfizer Investigational Site
Leuven, Belgium
Pfizer Investigational Site
Barranquilla, Atlántico, Colombia
Start Date
September 1, 2009
Primary Completion Date
June 1, 2011
Completion Date
January 1, 2013
Last Updated
June 10, 2014
NCT07349667
NCT06718569
NCT02593006
NCT00048542
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions